| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/01/2023 | ABBOTT LABORATORIES | ABT | Sale | Common shares without par value | 943 | $100.70 | $95k | | 02/28/2023 |
| 02/28/2023 | ABBOTT LABORATORIES | ABT | Payment of Exercise | Common shares without par value | 7.6k | $99.77 | $761.3k | | 02/28/2023 |
| 02/17/2023 | ABBOTT LABORATORIES | ABT | Grant | Common shares without par value | 15.9k | $0.00 | $0 | | 02/17/2023 |
| 02/17/2023 | ABBOTT LABORATORIES | ABT | Grant | | 62.5k | $106.24 | $6.6M | | 02/17/2023 |
| 06/10/2022 | ABBOTT LABORATORIES | ABT | Payment of Exercise | Common shares without par value | 2.9k | $112.71 | $324.8k | | 06/10/2022 |
| 06/10/2022 | ABBOTT LABORATORIES | ABT | Payment of Exercise | Common shares without par value | 19.6k | $112.71 | $2.2M | | 06/10/2022 |
| 03/01/2022 | ABBOTT LABORATORIES | ABT | Sale | Common shares without par value | 943 | $118.15 | $111.4k | | 02/28/2022 |
| 02/28/2022 | ABBOTT LABORATORIES | ABT | Payment of Exercise | Common shares without par value | 5.2k | $122.41 | $632.6k | | 02/28/2022 |
| 02/18/2022 | ABBOTT LABORATORIES | ABT | Grant | Common shares without par value | 17.2k | $0.00 | $0 | | 02/18/2022 |
| 02/18/2022 | ABBOTT LABORATORIES | ABT | Grant | | 80.4k | $117.58 | $9.5M | | 02/18/2022 |
| 06/10/2021 | ABBOTT LABORATORIES | ABT | Payment of Exercise | Common shares without par value | 2.9k | $109.05 | $314.2k | | 06/10/2021 |
| 03/01/2021 | ABBOTT LABORATORIES | ABT | Sale | Common shares without par value | 943 | $120.61 | $113.7k | | 02/26/2021 |
| 02/26/2021 | ABBOTT LABORATORIES | ABT | Payment of Exercise | Common shares without par value | 2.6k | $121.58 | $318.7k | | 02/26/2021 |
| 02/19/2021 | ABBOTT LABORATORIES | ABT | Grant | Common shares without par value | 13.9k | $0.00 | $0 | | 02/19/2021 |
| 02/19/2021 | ABBOTT LABORATORIES | ABT | Grant | | 71.1k | $124.04 | $8.8M | | 02/19/2021 |
| 06/10/2020 | ABBOTT LABORATORIES | ABT | Payment of Exercise | Common shares without par value | 2.9k | $90.27 | $257.7k | | 06/10/2020 |
| 06/10/2020 | ABBOTT LABORATORIES | ABT | Sale | Common shares without par value | 872 | $90.84 | $79.2k | | 06/10/2020 |
| 02/21/2020 | ABBOTT LABORATORIES | ABT | Grant | | 114.9k | $87.72 | $10.1M | | 02/21/2020 |
| 02/21/2020 | ABBOTT LABORATORIES | ABT | Grant | Common shares without par value | 18.9k | $0.00 | $0 | | 02/21/2020 |
| 07/24/2019 | Intersect ENT, Inc. | XENT | Grant | Stock Option (Right to buy) | 48.3k | $1.20 | $58k | | 07/24/2019 |
| 07/24/2019 | Intersect ENT, Inc. | XENT | Disposition | Stock Option (Right to buy) | 44.6k | $33.95 | $1.5M | | 07/24/2019 |
| 07/24/2019 | Intersect ENT, Inc. | XENT | Grant | Stock Option (Right to buy) | 44.6k | $33.95 | $1.5M | | 07/24/2019 |
| 07/24/2019 | Intersect ENT, Inc. | XENT | Disposition | Stock Option (right to buy) | 19.7k | $28.58 | $562.7k | | 07/24/2019 |
| 07/24/2019 | Intersect ENT, Inc. | XENT | Grant | Stock Option (right to buy) | 19.7k | $28.58 | $562.7k | | 07/24/2019 |
| 07/24/2019 | Intersect ENT, Inc. | XENT | Disposition | Stock Option (Right to buy) | 150k | $21.06 | $3.2M | | 07/24/2019 |
| 07/24/2019 | Intersect ENT, Inc. | XENT | Grant | Stock Option (Right to buy) | 150k | $21.06 | $3.2M | | 07/24/2019 |
| 07/24/2019 | Intersect ENT, Inc. | XENT | Disposition | Stock Option (Right to buy) | 196.9k | $18.90 | $3.7M | | 07/24/2019 |
| 07/24/2019 | Intersect ENT, Inc. | XENT | Grant | Stock Option (Right to buy) | 196.9k | $18.90 | $3.7M | | 07/24/2019 |
| 07/24/2019 | Intersect ENT, Inc. | XENT | Disposition | Stock Option (Right to buy) | 45.5k | $13.05 | $593.8k | | 07/24/2019 |
| 07/24/2019 | Intersect ENT, Inc. | XENT | Grant | Stock Option (Right to buy) | 45.5k | $13.05 | $593.8k | | 07/24/2019 |
| 07/24/2019 | Intersect ENT, Inc. | XENT | Disposition | Stock Option (Right to buy) | 48.3k | $1.20 | $58k | | 07/24/2019 |
| 06/10/2019 | ABBOTT LABORATORIES | ABT | Grant | Common shares without par value | 17.4k | $0.00 | $0 | | 06/10/2019 |
| 06/10/2019 | ABBOTT LABORATORIES | ABT | Grant | Common shares without par value | 39.5k | $0.00 | $0 | | 06/10/2019 |
| 06/10/2019 | ABBOTT LABORATORIES | ABT | Grant | | 91.4k | $80.98 | $7.4M | | 06/10/2019 |
| 05/15/2019 | Intersect ENT, Inc. | XENT | Sale | Common Stock | 9.5k | $25.59 | $243.1k | | 05/15/2019 |
|